Summary
- An Lp(a) concentration of ≥50 mg/dL (≥100/125 nmol/L) is widely considered to be elevated
- Most currently available Lp(a) assays can be used for cardiovascular (CV) risk stratification
- International guidelines recommend Lp(a) measurement at least once in adult life
Please login or create a FREE account to view this content
See more articles in our Back to Basics series
- What is Lp(a)?
- Lp(a) and cardiovascular disease
- Lp(a) and current lipid lowering therapies
- Why test Lp(a)?
Back to Basics Slide Deck Resource available now
A collection of state-of-the-art slide decks providing an accessible introduction to the growing body of evidence supporting Lp(a) as an independent risk factor for atherosclerotic cardiovascular disease (ASCVD) and aortic valve stenosis, including in individuals with low LDL-cholesterol levels.
